Power of Attorney

Each of the undersigned entities and individuals (collectively, the "Reporting
Persons") hereby authorizes and designates Westlake BioPartners GP II, LLC or
such other person or entity as is designated in writing by Beth C. Seidenberg
(the "Designated Filer") as the beneficial owner to prepare and file on behalf
of such Reporting Person individually, or jointly together with the other
Reporting Persons, any and all reports, notices, communications and other
documents (including, but not limited to, reports on Form D, Form ADV, Schedule
13D, Schedule 13F, Schedule 13G, Schedule 13H, Form 3, Form 4 and Form 5) that
such Reporting Person may be required to file with the United States Securities
and Exchange Commission pursuant to the Securities Act of 1933, as amended
(together with the implementing regulations thereto, the "Act") and the
Securities Exchange Act of 1934, as amended (together with the implementing
regulations thereto, the "Exchange Act") or any other domestic or international
state, federal or national agency (collectively, the "Reports") with respect to
each Reporting Person's ownership of, or transactions in, securities of any
entity whose securities are beneficially owned (directly or indirectly) by such
Reporting Person (collectively, the "Companies").

Each Reporting Person hereby further (i) authorizes and designates Jennifer L.
Kercher (the "Authorized Signatory") to execute and file on behalf of such
Reporting Person the Reports and to perform any and all other acts, which in the
opinion of the Designated Filer or Authorized Signatory may be necessary or
incidental to the performance of the foregoing powers herein granted and (ii)
approves and ratifies all prior Reports executed and/or filed on behalf of each
such Reporting Person by the Authorized Signatory.

The authority of the Designated Filer and the Authorized Signatory under this
Power of Attorney with respect to each Reporting Person shall continue until
such Reporting Person is no longer required to file any Reports with respect to
the Reporting Person's ownership of, or transactions in, the securities of the
Companies, unless earlier revoked in writing.  Each Reporting Person
acknowledges that the Designated Filer and the Authorized Signatory are not
assuming any of the Reporting Person's responsibilities to comply with the Act
or the Exchange Act.

Date: May 4, 2023

WESTLAKE BIOPARTNERS FUND II, L.P.
a Delaware Limited Partnership
By:	Westlake BioPartners GP II, LLC
	a Delaware Limited Liability Company
	Its General Partner

By:	/s/ Sean E. Harper
	Sean E. Harper
	Managing Director

By:	/s/ Beth C. Seidenberg
	Beth C. Seidenberg
	Managing Director

WESTLAKE BIOPARTNERS GP II, LLC
a Delaware Limited Liability Company


By:	/s/ Sean E. Harper
	Sean E. Harper
	Managing Director

By:	/s/ Beth C. Seidenberg
	Beth C. Seidenberg
	Managing Director


BETH C. SEIDENBERG
By: /s/ Beth C. Seidenberg

SEAN E. HARPER
By: /s/ Sean E. Harper